Veterinary Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Veröffentlicht von: precision business insights
Veröffentlicht am: 15.02.2018 11:09
Rubrik: Gesundheit & Medizin

(Presseportal openBroadcast) - Veterinary Pharmaceuticals Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023


Veterinary pharmaceuticals market report gives a comprehensive outlook on Veterinary pharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on veterinary pharmaceuticals market gives historical, current, and future market sizes (US$ Bn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies veterinary pharmaceuticals market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, veterinary pharmaceuticals market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed veterinary pharmaceuticals market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the veterinary pharmaceuticals market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of veterinary pharmaceuticals.

A sample of this report is available upon request @

Global Veterinary Pharmaceuticals Market:

Global veterinary pharmaceuticals market estimated to be valued US$ 18.1 Bn in 2017 and poised to grow at CAGR of 6.2% over 2017-2023. Market for veterinary pharmaceuticals projected to reach US$ 25.9 Bn by 2023 owing to rise in meat consumption and increased incidence of zoonotic diseases

The rising demand for protein food expected to dive veterinary pharmaceutical market revenue growth

The demand for protein food such as meat, milk, and eggs across the different geographies expected to drive the market for veterinary pharmaceuticals across the globe. Moreover, the rising demand for meat prompt the cattlemen and slaughterhouses to adopt good hygienic practices to provide better healthcare to the cattle and livestock animals, which projected to boost market revenue growth of veterinary pharmaceuticals over the forecast period. As per UN Food and Agricultural Organization (FAO) estimates that animal protein production such as poultry, beef, swine are expected to double, as well as dairy, and fish production anticipated to grow triple by 2050.

To view TOC of this report is available upon request @

Limited Research and development activities dampening the market revenue growth

Veterinary pharmaceutical market growth expected to hinder owing to the dearth of research and development activities and limited new drug approvals in the recent times. Players in the market focusing majorly on building an existing portfolio that may lead to product maturity in near-term and that may hamper the market growth over the forecast period. Moreover, competition from generic players and OTC drugs are hindering the market revenue growth

North America market leads the global veterinary pharmaceuticals market

Currently, North America market leads the global veterinary pharmaceuticals market and projected to remain same over the forecast period owing to rising consumption of protein food. Europe veterinary pharmaceuticals market holds a significant share in global veterinary pharmaceuticals market and projected to grow at significant CAGR.

Competition Assessment

Key players profiles in the global Veterinary Pharmaceuticals market include:
• Bayer AG (Germany)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Santι Animale (France)
• Eli Lilly and Company (U.S)
• Heska Co. (U.S)
• Hester Biosciences (India)
• Merck & Co., Inc. (U.S)
• Perrigo Company plc. (Ireland)
• Vιtoquinol S.A. (France)
• Virbac S.A. (France)
• Zoetis Inc. (U.S)
Players in the veterinary pharmaceuticals market are launching the newer products in the market to garner larger market share. For instance, in 2016, Merck Animal Health launched Nobivac Canine Flu Bivalent vaccine in U.S market – the first vaccine to aid in the control of disease associated with both canine influenza virus (CIV) H3N2 and canine influenza virus H3N8.

Need more information about this report @

Key Findings of the Report:

• Veterinary pharmaceuticals market expanding at 6.2% CAGR over 2017 to 2023 to reach market value of US$ 25.9 Bn by 2023
• Based on product type antimicrobials accounted for larger market revenue share in 2016 and projected gain larger market revenue share over the forecast period
• Veterinary pharmacies distribution channel is the prime source for veterinary pharmaceuticals across the globe and expected to remain attractive over the forecast period
• Players focusing on launching products to retain market position in global veterinary pharmaceuticals market
Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation

By Product Type
• Antimicrobials
• Ectoparasiticides
• Endoparasites
• Endectoparaciticides
• Anti-inflammatory Drugs
• Anti-Obesity Drugs
• Behavioral Products
• Biologic Drugs
• Others

By Animal Type
• Farm Animals
o Livestock
o Poultry
o Swine
o Equine
• Companion Animals
o Feline
o Canine
o Avian
• Aquaculture

By Route of Administration
• Oral
• Parenteral
• Topical
• Others
Distribution Channel
• Veterinary Pharmacies
• Veterinary Hospitals
• Veterinary Clinics
• E-Commerce

• North America
o U.S.
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Poland
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific
• Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America
• The Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

Get access to full summary @

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Toll Free (US): +1-866-598-1553
Website @

Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.